CAPRICOR THERAPEUTICS, INC. Logo

CAPRICOR THERAPEUTICS, INC.

A clinical-stage biotech developing cell and exosome-based biologics for serious diseases.

CAPR | US

Overview

Corporate Details

ISIN(s):
US14070B3096
LEI:
Country:
United States of America
Address:
10865 ROAD TO THE CURE, 92121 SAN DIEGO

Description

Capricor Therapeutics is a clinical-stage biotechnology company focused on the development of biologics, primarily cell and exosome-based technologies. The company's science is centered on its proprietary platform of allogeneic cardiosphere-derived cells (CDCs) and engineered exosomes to create novel therapeutics. Its lead candidate, Deramiocel (CAP-1002), is a cell therapy that has completed a pivotal Phase 3 study for the treatment of Duchenne muscular dystrophy (DMD). Capricor's pipeline leverages its core technologies to treat or prevent a broad range of serious diseases with significant unmet medical needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-01-07 01:00 English ZIP 7.9 KB
2025-01-02 20:17
8-K
English ZIP 97.4 KB
2024-12-16 15:25 English ZIP 7.7 KB
2024-12-05 02:00 English ZIP 7.5 KB
2024-11-14 22:30
10-Q
English ZIP 1.5 MB
2024-11-13 22:02
8-K
English ZIP 123.8 KB
2024-11-12 17:46 English ZIP 13.8 KB
2024-11-12 06:15 English ZIP 5.3 KB
2024-11-08 15:00
CAPRICOR THERAPEUTICS, INC.
English ZIP 14.5 KB
2024-11-06 22:36 English ZIP 9.3 KB
2024-10-28 21:36 English ZIP 57.8 KB
2024-10-24 20:02 English ZIP 13.8 KB
2024-10-22 23:11
S-3
English ZIP 102.8 KB
2024-10-17 22:15
424B5
English ZIP 161.5 KB
2024-10-17 12:01
8-K
English ZIP 276.0 KB

Automate Your Workflow. Get a real-time feed of all CAPRICOR THERAPEUTICS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CAPRICOR THERAPEUTICS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CAPRICOR THERAPEUTICS, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Advicenne Logo
A specialty pharmaceutical company developing treatments for rare renal diseases.
France
ALDVI
AegirBio AB Logo
A diagnostics company specializing in therapeutic drug monitoring for biological drugs.
Sweden
AEGIR
Aelis Farma Logo
Biopharmaceutical company developing CB1 receptor inhibitors for CNS disorders.
France
AELIS
AEON Biopharma, Inc. Logo
Clinical-stage company developing therapeutic applications for botulinum toxins.
United States of America
AEON
AFC-HD AMS Life Science Co.,Ltd. Logo
An OEM of health foods, supplements, and cosmetics with integrated R&D and manufacturing.
Japan
2927
AGENUS INC Logo
A clinical-stage biotechnology company specializing in immuno-oncology therapies.
United States of America
AGEN
AGIOS PHARMACEUTICALS, INC. Logo
Biopharmaceutical company developing therapies for rare and genetically defined diseases.
United States of America
AGIO
AHN-GOOK PHARMACEUTICAL Co., Ltd. Logo
Develops and markets medicines, focusing on respiratory and cardiovascular treatments.
South Korea
001540
Akari Therapeutics Plc Logo
Develops next-gen antibody-drug conjugates using proprietary cancer-killing toxins.
United States of America
AKTX
Akebia Therapeutics, Inc. Logo
A biopharmaceutical company that develops and commercializes therapeutics for kidney disease.
United States of America
AKBA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.